Stemedica Cell Technologies Inc., , announced today that Universal Stabilization Technologies has granted to Stemedica subsidiary StemProtein, LLC, an exclusive worldwide license to its technology known as Preservation by Vaporization for industrial scale stabilization of stem cells and stem cell derivatives. This license will allow Stemedica and StemProtein to manufacture stem cell-secreted therapeutic proteins in a VitriLife state, that remain shelf stable and therapeutically active at ambient temperatures for two or more years.
http://ift.tt/1y1qKil
http://ift.tt/1y1qKil
No comments:
Post a Comment